Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.

@article{Kuo2011InhibitionOH,
  title={Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.},
  author={Y -C. Kuo and Cheng-Te Liang},
  journal={Biomaterials},
  year={2011},
  volume={32 12},
  pages={
          3340-50
        }
}
Innovated catanionic solid lipid nanoparticles (CASLNs) carrying carmustine (BCNU) (BCNU-CASLNs) were grafted with anti-epithelial growth factor receptor (EGFR) (anti-EGFR/BCNU-CASLNs) and applied to inhibiting the propagation of human brain malignant glioblastomas cells. U87MG cells were treated with anti-EGFR/BCNU-CASLNs and stained for the expression of EGFR. The minimal average diameter of BCNU-CASLNs and maximal entrapment efficiency of BCNU emerged when the concentration of catanionic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

Biological activity of SDS-CTAB catanionic vesicles in cultured cells and assessment of their cytotoxicity ending in apoptosis

  • C Aiello, P Andreozzi, CL Mesa, G. Risuleo
  • Colloids Surf B ;78:149e54
  • 2010
2 Excerpts

of bone marrow stromal cells with the uptake of heparin - functionalized poly ( lactide - co - glycolide ) nanoparticles during differentiation towards neurons

  • C Ortiz, L Caja, P Sancho, E Bertran, I Fabregat
  • 2010

Bifunctional Gd2O3/C nanoshells for MR imaging and NIR therapeutic applications

  • CC Huang, CH Su, WM Li, TY Liu, JH Chen, CS. Yeh
  • Adv Funct Mater ;19:249e58
  • 2009
1 Excerpt